Schedule a Call

SOP Authoring Pattern for AI-Augmented Manufacturing Operations

Executive Summary

Standard operating procedures are the connective tissue of pharmaceutical manufacturing. When AI components enter the workflow — vision systems that flag defective vials, predictive models that recommend parameter adjustments, anomaly detectors that escalate to QA — existing SOPs typically break in characteristic ways. They presume a fully human actor. They have no place to record the AI’s recommendation or the operator’s decision to override. They lack escalation paths for the situation where the AI and the operator disagree. They are silent on explainability expectations.

This article presents a SOP authoring pattern designed for AI-augmented manufacturing operations. The pattern is anchored on a three-role classification — AI as actor, AI as advisor, AI as monitor — that determines the SOP’s structure. We cover the anatomy of an AI-augmented SOP, the design of escalation paths that handle AI/operator disagreement, the treatment of AI explainability as an SOP requirement, alignment with GAMP 5 Second Edition’s AI guidance, and a practical authoring and deployment workflow that produces SOPs which pass inspection without being operationally fragile.

75% of FDA 483 observations citing AI or automated systems in pharma manufacturing relate to procedural controls — SOPs that did not adequately specify how human operators should interact with the automated component. The SOP layer is where AI inspection findings concentrate.1

Where Traditional SOPs Strain Under AI

Traditional manufacturing SOPs are written with a clear assumption: a human operator performs each step, records the result, and proceeds to the next step. When an automated system is involved, the SOP typically acknowledges the automation as a tool the operator uses (e.g., “start the agitator,” “read the temperature from the controller”). The agency of the workflow remains entirely human; the automation is instrumentation.

AI components break this assumption in three different ways depending on how they are deployed. Sometimes the AI is the actor — a vision system that decides which vials proceed and which are rejected. Sometimes the AI is the advisor — a model that recommends a parameter adjustment that the operator may accept or override. Sometimes the AI is the monitor — an anomaly detector that watches the process and escalates when patterns deviate from expectation. Each of these deployment modes requires a different SOP structure, and traditional SOPs presume only the instrumentation model.

The characteristic failures of SOPs that have not been adapted include: no documentation of when the AI was active during the operation, no mechanism for the operator to record an override decision, no escalation path when the AI’s output appears to be incorrect, no provision for the situation when the AI is unavailable or returning low-confidence outputs, and no integration with the AI’s audit trail. Each of these failures produces inspection findings when probed. Together, they constitute a substantial portion of the AI-related 483 observations the industry has seen in recent inspection cycles, as documented in RAPS Regulatory Focus coverage of AI-related inspection findings.

The objective of an AI-augmented SOP authoring pattern is to give quality and operations teams a defensible template structure that handles the three deployment modes cleanly, integrates with the AI’s audit trail, and produces documents that operators can actually execute under the time pressure of real manufacturing operations.

The Actor-Advisor-Monitor Pattern

The actor-advisor-monitor classification is the foundation of the authoring pattern. Each AI component used in the SOP is classified into one of three roles, and the classification determines the SOP structure for that component’s involvement.

AI as actor. The AI makes the operational decision and the operator does not normally intervene. Vision systems that release or reject vials are the canonical example. The SOP for an AI-as-actor component specifies the AI’s decision authority, the conditions under which the operator must intervene (typically low-confidence outputs, sensor faults, or system unavailability), the documentation that captures the AI’s decision in the batch record, and the escalation path when the operator does intervene.

AI as advisor. The AI produces a recommendation and the operator decides whether to accept it. Predictive parameter adjustment models are the canonical example. The SOP for an AI-as-advisor component specifies the conditions under which the AI’s recommendation is presented to the operator, the operator’s decision authority to accept or override, the documentation of the operator’s decision and rationale, and the review pathway when overrides are frequent or significant.

AI as monitor. The AI watches the process and escalates anomalies but does not normally interact with the operator’s primary workflow. Anomaly detection systems and trend monitoring models are the canonical examples. The SOP for an AI-as-monitor component specifies the conditions under which the monitor escalates, the recipient of the escalation, the response time expectations, the documentation of the escalation response, and the periodic review of monitor performance.

The classification matters because each role implies different SOP structure, different operator training, and different inspection focus. An AI-as-actor component’s SOP focuses on the decision authority and the override mechanism. An AI-as-advisor component’s SOP focuses on the operator’s decision process and the documentation of overrides. An AI-as-monitor component’s SOP focuses on the escalation pathway and the response discipline. Trying to handle all three with a single SOP template produces documents that are inadequate for each role.

AI RolePrimary SOP FocusDocumentation RequirementInspection Focus
ActorDecision authority and override pathAI decision + override (when applicable)Override frequency and rationale
AdvisorOperator decision processRecommendation + decision + rationaleOverride patterns and trend
MonitorEscalation pathway and responseEscalation event + response actionResponse timeliness and completeness

Anatomy of an AI-Augmented SOP

The AI-augmented SOP retains the structure of a traditional manufacturing SOP — purpose, scope, definitions, responsibilities, procedure, references — but adds or modifies several sections specifically for AI involvement. The pattern below works across the three AI roles, with role-specific variations within each section.

Purpose section. The purpose section explicitly identifies which AI components are involved in the procedure and what role each component plays. This is not boilerplate; it is the index that operators and inspectors use to understand the document’s scope.

Definitions section. The definitions section includes AI-specific terms: the AI component’s name, its role classification, its decision authority, its confidence threshold, its expected response time, and its escalation conditions. These definitions are referenced throughout the procedure.

Responsibilities section. The responsibilities section enumerates the roles involved — operator, QA, system owner, AI model owner — and specifies which decisions are made by which role. For AI-as-actor components, the responsibilities section is particularly important because it establishes that the AI itself has decision authority and that the operator’s role is calibrated accordingly.

Procedure section. The procedure section is the core of the document. Steps that involve AI components are written to explicitly include the AI’s action or recommendation, the operator’s interaction (if any), the documentation of both, and any conditional branches based on AI output. Each AI-involving step has a documented evidence pathway.

Override and escalation section. A dedicated section specifies the conditions under which the operator may or must override an AI decision or recommendation, the documentation required for the override, the notification path for significant overrides, and the periodic review of override patterns.

System unavailability section. A dedicated section specifies the procedure when the AI component is unavailable, returning low-confidence outputs, or returning suspect outputs. The fallback procedure must produce documentation that satisfies the same regulatory requirements as the AI-augmented procedure.

Documentation section. The documentation section specifies the batch record entries, the AI audit trail integration, and the supporting records required for each AI-involving step. The integration with the AI’s audit trail is critical: the batch record must reference the AI audit trail in a way that allows reviewers and inspectors to reconstruct the AI’s decision.

References section. The references section includes the AI component’s validation documentation, the model’s performance specification, and the change control history. This is the documentation pathway that connects the SOP to the underlying AI governance.

Sakara Digital perspective: The most common authoring failure we see is treating the AI as if it were just another piece of instrumentation. Instrumentation produces a reading; AI produces a decision or a recommendation. The SOP structure has to acknowledge the agency of the AI and provide the human operator with a defensible role in the decision flow. SOPs that get this right read clearly to both operators and inspectors. SOPs that get it wrong produce ambiguous procedures that are dangerous in operation and indefensible under inspection.

Designing Escalation Paths When AI Disagrees with the Operator

Escalation paths for AI/operator disagreement are among the most consequential design choices in the SOP. The disagreement scenarios cluster into three patterns: the AI recommends one action and the operator believes a different action is correct (advisor scenarios); the AI takes an action and the operator believes the action was incorrect (actor scenarios); and the AI does not escalate when the operator believes it should have (monitor scenarios).

For advisor scenarios, the SOP should establish a graduated escalation: operator override with rationale (always documented), supervisor notification for material overrides, QA review for overrides outside specification, and trend review for sustained override patterns. The threshold definitions — what constitutes a material override, what is outside specification — are critical and should be informed by the AI’s validated performance and the manufacturing context.

For actor scenarios, the SOP should establish the conditions under which the operator may intervene after the AI has acted (typically a quality hold pathway), the documentation of the intervention and rationale, and the post-event review that determines whether the AI’s action was correct or whether the intervention was warranted. The post-event review is essential for learning: if operator interventions consistently identify AI errors, the AI’s validated performance is being degraded and the system requires reassessment.

For monitor scenarios, the SOP should establish the operator’s authority to escalate manually when the monitor has not, the documentation of the manual escalation, and the review pathway that compares manual escalations to monitor performance. If operators consistently escalate cases the monitor missed, the monitor’s threshold or training requires reassessment.

The escalation design is calibrated by the AI’s role classification and by the operational consequence of the disagreement. High-consequence disagreements warrant tighter escalation and more comprehensive review; low-consequence disagreements can use lighter mechanisms. The calibration produces escalation paths that are workable in normal operations without producing operational paralysis.

Treating AI Explainability as an SOP Requirement

AI explainability is often treated as a model design property rather than an SOP requirement. In manufacturing operations, the SOP layer is where explainability becomes operationally consequential: the operator must understand why the AI made a recommendation in order to evaluate whether to accept it; the QA reviewer must understand why the AI made a decision in order to assess the batch record; the inspector must understand the AI’s decision in order to evaluate compliance.

The SOP can specify several explainability requirements. First, the AI’s output must be accompanied by the relevant inputs that drove the recommendation or decision — what readings, parameters, or images the AI considered. Second, the AI’s confidence level must be reported alongside the output, so the operator can calibrate trust appropriately. Third, the AI’s reference to the most influential factors in its decision (often called feature attribution or contribution analysis) should be displayed when available. Fourth, the AI’s reference to the relevant validation evidence (model version, validation date, performance specification) should be retrievable from the operator’s interface.

These requirements do not transform the AI into a fully interpretable system. They produce explanation surface — a layer of information that the operator can use to evaluate the AI’s output in the operational moment. The SOP makes the explanation surface part of the procedure rather than leaving it to the AI’s vendor or to ad hoc operator practice. The GAMP 5 Second Edition guide articulates explainability as a core design consideration for AI in regulated environments, and the SOP layer is where the design consideration translates into operational practice.

For AI-as-actor components, the explanation surface is consumed primarily by the operator during exception scenarios and by the QA reviewer during batch record review. For AI-as-advisor components, the explanation surface is consumed by the operator during the decision moment, which places real-time performance requirements on the explanation interface. For AI-as-monitor components, the explanation surface is consumed by the escalation recipient and during periodic monitor performance review.

GAMP 5 Second Edition Alignment

ISPE published GAMP 5 Second Edition in July 2022, and the AI/ML-specific guidance in the second edition (and its 2025 AI Guide complement) has become the de facto industry reference for AI in pharma manufacturing. The SOP authoring pattern described here aligns with the GAMP 5 framework in several specific ways.

GAMP 5 emphasizes risk-based, lifecycle approaches to system management. The actor-advisor-monitor classification is a risk-based framing that maps cleanly to GAMP’s category-based thinking. The role classification informs the depth of SOP detail, the override discipline, and the monitoring expectations — all of which align with GAMP’s risk-based posture.

GAMP 5 emphasizes that procedural controls are part of the validated state of a computerized system. SOPs are not separate from validation; they are part of the validated state and require change control like any other validated artifact. The authoring pattern described here treats SOPs as validated artifacts with explicit linkage to AI component validation, which aligns with GAMP’s lifecycle framing.

GAMP 5 Second Edition’s AI guidance specifically addresses the need for operator training calibrated to the AI’s role, for documented evidence of operator competence, and for periodic refresher training as the AI’s behavior evolves. The SOP authoring pattern produces SOPs that explicitly reference the operator training requirements, which supports the GAMP-aligned training discipline.

For pharma organizations that have not yet adopted GAMP 5 Second Edition’s AI guidance formally, the SOP authoring pattern provides a practical entry point. The SOPs produced under the pattern are GAMP-aligned in substance even before the formal GAMP adoption work is complete, which reduces the alignment debt of an eventual formal adoption.

Authoring, Reviewing, and Deploying AI-Augmented SOPs

The authoring and deployment workflow for AI-augmented SOPs differs from traditional SOP workflows in two material respects. First, the AI model owner is a required reviewer alongside the traditional QA and operations reviewers. Second, the SOP’s deployment is contingent on the AI component’s validated state being current and on the operator training being up to date.

The authoring workflow typically proceeds through these stages: an AI use case design document produced jointly by AI model owner and operations defines the AI’s role and the operational integration; a draft SOP produced by operations specifies the procedure including AI involvement; QA reviews the SOP for compliance structure and documentation pathway; the AI model owner reviews the SOP for accurate representation of the AI’s role and capabilities; the SOP is piloted with a small operator group to identify operability issues; the SOP is finalized with input from the pilot; the SOP enters change control and is approved for deployment.

The deployment workflow includes operator training on the AI’s role and the SOP’s procedure, a deployment readiness review that confirms the AI component is in validated state, and a deployment date that is coordinated with the AI component’s release. SOPs that reference an AI capability must not be deployed before the AI capability is validated and operational; SOPs that reference deprecated AI capabilities must be retired or revised before the deprecation takes effect.

The periodic review of the AI-augmented SOP is calibrated to the AI’s change cadence. AI components that update frequently — particularly vendor-managed models that update on a vendor-driven cadence — require more frequent SOP review than stable AI components. The change control discipline must track AI model updates and trigger SOP review when material updates occur, even when the SOP itself has not been changed.

Quality system integration

The SOP authoring pattern is most effective when integrated with the broader quality system, not implemented in isolation. The QMS should include: an AI use case inventory that lists all AI components in scope of GxP SOPs; an AI change control mechanism that triggers SOP review when material changes occur; an operator competence tracking mechanism that records training on AI-augmented SOPs; an override tracking mechanism that captures the documented overrides across the AI portfolio; and a periodic performance review that evaluates the AI’s operational performance across SOPs.

Each of these QMS extensions supports the SOP authoring pattern and produces the documented evidence that inspectors expect. Quality leaders building toward the pattern should treat these QMS extensions as part of the work, not as separate parallel projects.

Why this matters operationally

The operational stakes of the SOP authoring pattern are substantial. AI components are entering pharma manufacturing at an accelerating cadence, and the SOPs are the layer where the AI’s regulatory defensibility either holds or fails. Pharma quality leaders who treat SOP authoring as a tactical document-writing exercise are systematically underinvesting; leaders who treat it as a strategic discipline calibrated to the AI integration architecture are producing operational documents that scale with the AI portfolio and that hold up under inspection. The investment in the pattern is finite; the dividend is durable.

References & Sources

References & Sources

  1. FDA Warning Letters and 483 Observations Citing AI — RAPS Regulatory Focus. Practitioner analysis of FDA inspection findings related to AI and automated systems in pharma manufacturing, with focus on procedural control gaps.
  2. GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition) — ISPE. The de facto industry reference for computerized system validation, including AI-specific guidance.
  3. GAMP Guide: Artificial Intelligence — ISPE. The 2025 ISPE guide specifically addressing AI in regulated pharma environments, including operator interface and procedural control expectations.
  4. Quality Considerations for Continuous Manufacturing — FDA Guidance. FDA’s guidance on continuous manufacturing, which includes procedural control expectations relevant to AI-augmented manufacturing operations.
  5. Operational Considerations for the Use of AI in Biopharma — BioPhorum. Industry consortium guidance on operationalizing AI in biopharma manufacturing, with practical focus on procedural controls.
  6. ICH Q9(R1) Quality Risk Management — FDA / ICH. The international quality risk management guideline that informs the risk-based calibration of AI-augmented SOPs.
author avatar
Amie Harpe Founder and Principal Consultant
Amie Harpe is a strategic consultant, IT leader, and founder of Sakara Digital, with 20+ years of experience delivering global quality, compliance, and digital transformation initiatives across pharma, biotech, medical device, and consumer health. She specializes in GxP compliance, AI governance and adoption, document management systems (including Veeva QMS), program management, and operational optimization — with a proven track record of leading complex, high-impact initiatives (often with budgets exceeding $40M) and managing cross-functional, multicultural teams. Through Sakara Digital, Amie helps organizations navigate digital transformation with clarity, flexibility, and purpose, delivering senior-level fractional consulting directly to clients and through strategic partnerships with consulting firms and software providers. She currently serves as Strategic Partner to IntuitionLabs on GxP compliance and AI-enabled transformation for pharmaceutical and life sciences clients. Amie is also the founder of Peacefully Proven (peacefullyproven.com), a wellness brand focused on intentional, peaceful living.


Your perspective matters—join the conversation.

Discover more from Sakara Digital

Subscribe now to keep reading and get access to the full archive.

Continue reading